HFR Wealth Management’s AbbVie ABBV Stock Holding History

HFR Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Sell	1,413 -20	-1%	-$4.3K	0.09%	43
2026 Q1	$312K	Hold	1,433	–	–	0.08%	42
2025 Q4	$327K	Hold	1,433	–	–	0.08%	42
2025 Q3	$332K	Hold	1,433	–	–	0.08%	43
2025 Q2	$266K	Hold	1,433	–	–	0.06%	47
2025 Q1	$300K	Hold	1,433	–	–	0.07%	48
2024 Q4	$255K	Hold	1,433	–	–	0.06%	49
2024 Q3	$283K	Sell	1,433 -100	-7%	-$18.7K	0.07%	48
2024 Q2	$263K	Hold	1,533	–	–	0.07%	50
2024 Q1	$279K	Hold	1,533	–	–	0.07%	50
2023 Q4	$238K	Hold	1,533	–	–	0.06%	53
2023 Q3	$228K	Hold	1,533	–	–	0.07%	52
2023 Q2	$207K	Hold	1,533	–	–	0.06%	55
2023 Q1	$244K	Sell	1,533 -14	-0.9%	-$2.14K	0.07%	54
2022 Q4	$250K	Hold	1,547	–	–	0.07%	53
2022 Q3	$208K	Sell	1,547 -40	-3%	-$5.74K	0.07%	52
2022 Q2	$243K	Sell	1,587 -46	-3%	-$7.03K	0.07%	50
2022 Q1	$265K	Sell	1,633 -36	-2%	-$5.23K	0.07%	52
2021 Q4	$226K	Buy	+1,669	New	+$197K	0.06%	62

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HFR Wealth Management's ABBV Position: Q2 2026 in Review

HFR Wealth Management reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $4.3K and leaving 1,413 shares worth $356K. The position accounts for 0.09% of the portfolio, ranked #43.

HFR Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

HFR Wealth Management held 1,413 shares of AbbVie worth $356K as of Q2 2026.
HFR Wealth Management sold 20 AbbVie shares in Q2 2026, an estimated $4.3K.
AbbVie made up 0.09% of HFR Wealth Management's portfolio in Q2 2026, its #43 holding.
HFR Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HFR Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.